期刊
BIOMATERIALS
卷 156, 期 -, 页码 88-106出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2017.11.030
关键词
3D printing; Biomaterials; Tissue engineering; Regenerative medicine; In vitro tissue model; Personalized medicine
资金
- National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2010-0018294, 2015R1A6A3A04059015, 2017032067]
- Institute for Information AMP
- communications Technology (IITP) - Korea government (MSIP) [IITP-R0346-16-1007, 20170009530012003]
Building human tissues via 3D cell printing technology has received particular attention due to its process flexibility and versatility. This technology enables the recapitulation of unique features of human tissues and the all-in-one manufacturing process through the design of smart and advanced biomaterials and proper polymerization techniques. For the optimal engineering of tissues, a higher-order assembly of physiological components, including cells, biomaterials, and biomolecules, should meet the critical requirements for tissue morphogenesis and vascularization. The convergence of 3D cell printing with a microfluidic approach has led to a significant leap in the vascularization of engineering tissues. In addition, recent cutting-edge technology in stem cells and genetic engineering can potentially be adapted to the 3D tissue fabrication technique, and it has great potential to shift the paradigm of disease modeling and the study of unknown disease mechanisms required for precision medicine. This review gives an overview of recent developments in 3D cell printing and bioinks and provides technical requirements for engineering human tissues. Finally, we propose suggestions on the development of next generation therapeutics and diagnostics. (C) 2017 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据